Library / Laws / 115th Congress / Senate Bills / S. 124
S. 124
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2017-01-12 | 16.3K | ⠃⠗⠋ |